Anti-T antibody was obtained from xenogeneic antithymocyte serum by adsorption and elution with brain immunosorbent. Bone marrow and spleen cells from the parental A strain were treated in vitro with anti-T antibody and complement or with the original ATS and complement. So treated cells were assayed for the ability to induce a local and a total GVH reaction in (A X C57BL)F1 hybrid mice, to prolong the survival of lethally irradiated, identical F1 hybrid mice and to form haemopoietic colonies in spleens of the syngeneic irradiated recipients. The local GVH reaction induced by anti-T antibody- and ATS-treated spleen cells was somewhat lower. Administration of a mixture of spleen and bone marrow cells treated with anti-T antibody prolonged the survival of lethally irradiated recipients but did not prevent the consequences of late GVH reaction. The colony-forming activity of bone marrow cells treated with anti-T antibody was not reduced in most experiments. It can be concluded that the treatment of cells from mouse haemopoietic organs with anti-T antibody and complement damages mature T lymphocytes and in this way reduces the ability to induce GVH reaction, but does not damage T lymphocyte precursors and haemopoietic stem cells.

Download full-text PDF

Source

Publication Analysis

Top Keywords

anti-t antibody
24
bone marrow
16
gvh reaction
16
hybrid mice
12
cells
8
vitro anti-t
8
spleen cells
8
antibody complement
8
ability induce
8
survival lethally
8

Similar Publications

Background: Worldwide, there has been a worrying increase in the prevalence of syphilis. Blood banks have a major role in monitoring the trend of these events, despite the bias due to the altruistic donation strategy.

Objectives: To determine the seroprevalence of syphilis and analyse its association with defined risk factors among blood donors at the regional blood center at Hospital Prof.

View Article and Find Full Text PDF

Pourpose: This study aimed to investigate the seroepidemiological status of Toxoplasma gondii (T. gondii) infection in Multiple Sclerosis (MS) patients compared to controls.

Methods: The present study included 98 MS patients and 100 controls.

View Article and Find Full Text PDF

Serological Profile of Anti- Antibodies in Liver Transplant Recipients.

Trop Med Infect Dis

January 2025

Faculdade de Medicina de São José do Rio Preto (FAMERP), Avenida Brigadeiro Faria Lima, 5416, Vila São Pedro, São José do Rio Preto 15090-000, SP, Brazil.

, a globally distributed obligatory intracellular opportunistic parasite that has infected one third of the world population, has different transmission routes including via organ transplantation. The liver has emerged as a frequent transplanted organ in which the transmission of can occur between seropositive donors and seronegative recipients. Allied with immunosuppressive therapy, the presence of latent infection in recipients elevates the risk of severe toxoplasmosis.

View Article and Find Full Text PDF

Objective: This study retrospectively evaluates our laboratory immunoglobulin (Ig)M, IgG antibody and avidity test results to determine the distribution of the pathogen according to sex, age, clinics and years.

Methods: The serum samples sent to Pamukkale University Healthcare Research and Practice Hospital's Medical Microbiology laboratory between January 2016 and December 2023 were evaluated for seropositivity. antibodies and avidity testing were studied using chemiluminescent microparticle immunological testing method (Abbott Architect i2000SR, Weisbaden, Germany).

View Article and Find Full Text PDF

Background: Toxoplasma gondii is a zoonotic parasite with a great impact on the health of Neotropical primates (NP). The aim of this study was to compare the agreement between the immunofluorescent antibody test (IFAT) and the modified agglutination test (MAT) to detect IgG anti-T. gondii antibodies in NP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!